Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis

IF 2.9 4区医学 Q2 DERMATOLOGY

Journal of Dermatological Treatment Pub Date : 2023-12-11 DOI:10.1080/09546634.2023.2291317

Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

引用次数: 0

Abstract

Though Janus kinase inhibitors such as upadacitinib rapidly relieve itch in atopic dermatitis (AD) patients, how early itch relief impacts later skin clearance is not examined.This study aims to de...

查看原文本刊更多论文

使用奥达帕替尼早期缓解瘙痒可预测特应性皮炎后期的皮肤清除率

尽管达帕替尼（upadacitinib）等Janus激酶抑制剂能迅速缓解特应性皮炎（AD）患者的瘙痒，但早期瘙痒缓解如何影响日后的皮肤清除尚未得到研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Dermatological Treatment 医学-皮肤病学

CiteScore

6.50

自引率

0.00%

发文量

145

审稿时长

6-12 weeks

期刊介绍： The Journal of Dermatological Treatment covers all aspects of the treatment of skin disease, including the use of topical and systematically administered drugs and other forms of therapy. The Journal of Dermatological Treatment is positioned to give dermatologists cutting edge information on new treatments in all areas of dermatology. It also publishes valuable clinical reviews and theoretical papers on dermatological treatments.